Connexin hemichannels as candidate targets for cardioprotective and anti-arrhythmic treatments. Leybaert L, De Smet MA, Lissoni A, Allewaert R, et al. J Clin Invest 2023;133:e168117.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Leybaert L, De Smet MA, Lissoni A, Allewaert R, et al. Connexin hemichannels as candidate targets for cardioprotective and anti-arrhythmic treatments. J Clin Invest 2023;133:e168117.
PMID: 36919695